Report Library
View More
Non-Alcoholic Steatohepatitis (NASH...
July 19, 2024
Non-Alcoholic Steatohepatitis (NASH...
July 18, 2024
Respiratory Syncytial Virus (RSV) K...
July 17, 2024
Non-Small Cell Lung Cancer (NSCLC) ...
June 28, 2024
NHL: Diffuse Large B-Cell Lymphoma ...
June 27, 2024
NHL: Diffuse Large B-Cell Lymphoma ...
June 26, 2024
Ovarian Cancer KOL Interview - Fran...
June 24, 2024
Ovarian Cancer KOL Interview - US, ...
June 24, 2024
Hemophilia KOL Interview - US, West
June 20, 2024
Hemophilia KOL Interview - Belgium
June 18, 2024
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 7/25/24 | AstraZeneca (AZN) | Imfinzi for Non-Small Cell Lung Cancer (NSCLC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 7/25/24 | Chemomab Therapeutics (CMMB) | CM-101 for Primary Sclerosing Cholangitis (PSC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 7/24/24 | Pfizer (PFE) | Giroctocogene Fitelparvovec for Hemophilia A | Subscribers Only | Subscribers Only | Subscribers Only |
| 7/23/24 | AstraZeneca (AZN) | Imfinzi for Non-Small Cell Lung Cancer (NSCLC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 7/23/24 | Bausch Health (BHC) | Mytesi for Gastroenterologic Disorders | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 01/01/25 - 04/30/24 | Subscribers Only | Subscribers Only | Progress Update - Product Launch |
| 01/01/25 - 06/30/24 | Subscribers Only | Subscribers Only | Regulatory - MAA Submission (Europe) |
| 07/27/24 | Subscribers Only | Subscribers Only | Regulatory - PDUFA/Approval Decision (U.S.) |
| 07/28/24 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 07/28/24 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |